Torrent Pharma
NSE
₹ 0.00
0.00 (0.00)%
Large-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
18 05 2021 | Audited Results & Final Dividend Inter alia, the Board would also consider the following: i. Payment of Final Dividend for the year 2020-21. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders approval in the ensuing Annual General Meetin |
27 07 2021 | Quarterly Results |
26 10 2021 | Quarterly Results |
25 01 2022 | Quarterly Results & Interim Dividend |
25 05 2022 | Final Dividend & Bonus issue & Audited Results |
29 07 2022 | Quarterly Results |
21 10 2022 | Quarterly Results |
25 01 2023 | Quarterly Results & Interim Dividend |
30 05 2023 | Final Dividend & Audited Results |
07 08 2023 | Quarterly Results |
23 10 2023 | Quarterly Results |
02 02 2024 | Quarterly Results & Interim Dividend |
25 10 2024 | Quarterly Results |
24 01 2025 | Quarterly Results & Interim Dividend |
No News data available